Lantern Pharma
LTRN
LTRN
32 hedge funds and large institutions have $8M invested in Lantern Pharma in 2024 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
3% more funds holding
Funds holding: 31 → 32 (+1)
20% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 10
Holders
32
Holding in Top 10
1
Calls
$16K
Puts
$2K
Top Buyers
| 1 | +$160K | |
| 2 | +$113K | |
| 3 | +$48.1K | |
| 4 |
CM
CM Management
Gulf Breeze,
Florida
|
+$47.9K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$14.1K |
Top Sellers
| 1 | -$220K | |
| 2 | -$89.3K | |
| 3 | -$62.4K | |
| 4 |
Two Sigma Investments
New York
|
-$56.8K |
| 5 |
PWM
Perigon Wealth Management
San Francisco,
California
|
-$51.5K |